BGCAX
2014 | 2015 | 2016 | 2017 | 2018 | |
---|---|---|---|---|---|
Total Return (%) Total return represents changes to the NAV and accounts for distributions from the fund. | 0.67 | -1.22 | 3.28 | 3.21 | -1.99 |
Annual w/ Sales Charge (%) Max Sales Charge: - | -3.36 | -5.17 | -0.85 | -0.92 | -5.91 |
Benchmark (%) Index: ICE BofAML 3 Month Treasury Bill Index (G0O1)<br /><br /> Index returns are for illustrative purposes only. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results. | 0.03 | 0.05 | 0.33 | 0.86 | 1.87 |
Morningstar Category Avg. (%) Long-Short Credit | 2.62 | -2.58 | 4.54 | 2.44 | -1.64 |
Interactive chart displaying fund performance. Javascript is required.
Net Expense Ratio excluding Investment Related Expenses is 1.30%
Name | Fund Weight (%) |
---|---|
MANTA HOLDINGS LP | 2.04 |
INTELSAT HOLDINGS SA | 1.89 |
ITHACA HOLDCO 2 LLC | 1.80 |
SOFTBANK GROUP CORP | 1.73 |
ADVANCED MICRO DEVICES INC | 1.56 |
Name | Fund Weight (%) |
---|---|
KENTUCKY HOSPITAL HOLDINGS LLC | 1.51 |
LIBERTY GLOBAL PLC | 1.49 |
BAUSCH HEALTH COMPANIES INC | 1.37 |
AMERICAN AIRLINES PASS THROUGH TRUSTS | 1.35 |
HCA INC | 1.23 |
Name | Fund Weight (%) |
---|---|
ITRAXX.EUR.30.V1 | -1.70 |
ITRAXX.XO.30.V2 | -1.62 |
CDX.NA.IG.31.V1 | -1.53 |
JPMORGAN CHASE & CO | -1.36 |
CDX.NA.HY.31.V1 | -1.20 |
Name | Fund Weight (%) |
---|---|
ITALY (REPUBLIC OF) | -1.15 |
CDX.NA.HY.30.V1 | -1.04 |
RAYTHEON COMPANY | -0.96 |
NEXT PLC | -0.92 |
CATERPILLAR INC | -0.86 |
% of Market Value
% of Market Value
% of Market Value
% of Market Value
These sectors may contain hedge positions intended to bring the portfolio to a neutral duration and/or currency positioning and are not deemed active credit positions.
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.
Allocations are subject to change.